DK0757556T3 - Borrelia Burgdorferi-bakterin - Google Patents

Borrelia Burgdorferi-bakterin

Info

Publication number
DK0757556T3
DK0757556T3 DK95916950T DK95916950T DK0757556T3 DK 0757556 T3 DK0757556 T3 DK 0757556T3 DK 95916950 T DK95916950 T DK 95916950T DK 95916950 T DK95916950 T DK 95916950T DK 0757556 T3 DK0757556 T3 DK 0757556T3
Authority
DK
Denmark
Prior art keywords
borrelia burgdorferi
bacterin
crossprotective
antigenic
isolates
Prior art date
Application number
DK95916950T
Other languages
English (en)
Inventor
Jon B Korshus
Paul L Runnels
Richard L Sharpee
Ronald F Schell
Steven M Callister
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0757556T3 publication Critical patent/DK0757556T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK95916950T 1994-04-11 1995-04-11 Borrelia Burgdorferi-bakterin DK0757556T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22629794A 1994-04-11 1994-04-11

Publications (1)

Publication Number Publication Date
DK0757556T3 true DK0757556T3 (da) 2006-10-02

Family

ID=22848351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95916950T DK0757556T3 (da) 1994-04-11 1995-04-11 Borrelia Burgdorferi-bakterin

Country Status (9)

Country Link
US (5) US6316005B1 (da)
EP (1) EP0757556B1 (da)
AT (1) ATE329615T1 (da)
CA (1) CA2187535C (da)
DE (1) DE69535059T2 (da)
DK (1) DK0757556T3 (da)
ES (1) ES2265643T3 (da)
PT (1) PT757556E (da)
WO (1) WO1995027504A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0757556B1 (en) * 1994-04-11 2006-06-14 Wyeth Holdings Corporation Borrelia burgdorferi bacterin
BRPI0719360B1 (pt) * 2006-11-03 2016-09-06 Intervet Int Bv vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia
CZ301244B6 (cs) * 2007-11-14 2009-12-16 Bioveta, A.S. Univerzální vakcína k lécbe a prevenci Lymeské borreliózy pro humánní a veterinární použití a zpusob její výroby
CZ301548B6 (cs) * 2008-08-20 2010-04-14 Bittner@Libor Univerzální preparát ke zvýšení obranyschopnosti, prevenci, profylaxi a lécbe Lymeské boreliózy pro humánní a veterinární použití, zpusob jeho výroby a použití
RU2013118647A (ru) * 2010-09-27 2014-11-10 Корнелл Юниверсити Способы диагностики болезни лайма
WO2013049039A1 (en) * 2011-09-30 2013-04-04 Advanced Laboratory Services, Inc. Compositions and methods for culturing spirochetes
US9128584B2 (en) * 2013-02-15 2015-09-08 Carl Zeiss X-ray Microscopy, Inc. Multi energy X-ray microscope data acquisition and image reconstruction system and method
BR112020011041A2 (pt) 2017-12-04 2020-11-17 Intervet International B.V. vacina contra a doença de lyme canina

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4002736A (en) * 1974-12-16 1977-01-11 Pankratz Duane C Porcine bacterin
US4171354A (en) * 1977-06-23 1979-10-16 Ohio Agricultural Research And Development Center Vaccine for animal respiratory diseases
US4223014A (en) * 1978-05-08 1980-09-16 The United States Of America As Represented By The Secretary Of The Interior Spray immunization of fish
US4423035A (en) * 1981-08-10 1983-12-27 Schering Corporation Method for preventing injection site abscess
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US4818528A (en) * 1987-02-06 1989-04-04 The University Of Tennessee Research Corporation Vaccine against infectious bovine keratoconjunctivitis
US5248501A (en) * 1988-11-22 1993-09-28 Parnell Pharmaceuticals Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith
CA2011896C (en) * 1989-04-21 2001-05-08 Mark Werner Ringworm vaccine
US5385826A (en) * 1989-04-21 1995-01-31 Gundersen Medical Foundation, Ltd. Diagnostic assay for lyme disease
US5582829A (en) * 1990-04-05 1996-12-10 Rx Technologies, Inc. Sonicated borrelia burgdorferi vaccine
JPH06501382A (ja) * 1990-06-15 1994-02-17 エール ユニバーシティ ライム病の予防および診断に用いる組成物および方法
EP1016416A3 (en) * 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
JPH07501687A (ja) * 1991-08-15 1995-02-23 スミスクライン・ビーチャム・バイオロジカルス（ソシエテ・アノニム） ボレリア・ブルグドルフェリのサブグループのｏｓｐ　ａ　蛋白、それをコードしている遺伝子およびワクチン
AU2903892A (en) * 1991-10-22 1993-05-21 Symbicom Aktiebolag Improvement in (borrelia burgdorferi) diagnosis and prophylaxis
ATE173166T1 (de) * 1992-09-04 1998-11-15 Univ Saskatchewan Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
US5656451A (en) * 1993-07-30 1997-08-12 Yale University OspE, OspF, and S1 polypeptides in borrelia burgdorferi
US6303130B1 (en) * 1993-11-02 2001-10-16 The United States Of America As Represented By The Secretary Of Agriculture Pasteurella haemolytica vaccine inactivated by ultraviolet light
EP0757556B1 (en) * 1994-04-11 2006-06-14 Wyeth Holdings Corporation Borrelia burgdorferi bacterin
US6673346B1 (en) * 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2005096823A1 (en) * 2004-04-01 2005-10-20 The Research Foundation Of State University Of New York At Buffalo Vaccine for nontypeable haemophilus influenzae infection
BRPI0719360B1 (pt) * 2006-11-03 2016-09-06 Intervet Int Bv vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia

Also Published As

Publication number Publication date
CA2187535C (en) 2011-09-13
EP0757556A1 (en) 1997-02-12
DE69535059D1 (en) 2006-07-27
PT757556E (pt) 2006-10-31
CA2187535A1 (en) 1995-10-19
DE69535059T2 (de) 2007-01-18
EP0757556B1 (en) 2006-06-14
ATE329615T1 (de) 2006-07-15
US20020071851A1 (en) 2002-06-13
WO1995027504A1 (en) 1995-10-19
US20050042235A1 (en) 2005-02-24
US20080026009A1 (en) 2008-01-31
ES2265643T3 (es) 2007-02-16
US6316005B1 (en) 2001-11-13
US20110256178A1 (en) 2011-10-20
EP0757556A4 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
GB9713156D0 (en) Vaccines
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
HUP0400687A2 (hu) Mycoplasma hyopneumoniae bakterin-vakcina
DK0672116T3 (da) Deletionsmutanter som vacciner mod kolera
AU4188100A (en) Dry formulation for transcutaneous immunization
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
ATE315405T1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
DK0764029T3 (da) Proteinadjuvanser
NZ309713A (en) Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
EP0804489A4 (da)
DK0757556T3 (da) Borrelia Burgdorferi-bakterin
FI972054A0 (fi) Immunogeenisiä koostumuksia
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
FI971402A0 (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
AU4537100A (en) Adjuvant combinations for immunization composition and vaccines
AU6435596A (en) Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
EP0952771A4 (en) SAPONIN COMPOSITIONS AND THEIR USE
IL117151A0 (en) Novel antigen
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines